Bodybuilders and others who wish to boost muscle growth can make use of Dindolyl Methane (or DIM). Recent studies have revealed that DIM could pose health hazards. DIM can cause liver damage when taken in excess. A related risk is kidney damage, which could lead to kidney failure. The possible long term health risks associated with DIM have many bodybuilders and athletes think about the question: should I supplement my diet with an supplement with DIM?
To boost testosterone production it is common to take diindolylmethane supplement. Testosterone is known to act as an anandrogen, meaning that it causes hormonal changes in tissues. DIM has been shown in studies to mimic the effects of testosterone, as well as other hormones. Certain manufacturers have added diindolylmethane (DIM) to their products to boost their popularity in male circles since men are more likely to produce testosterone than women. The theory is that men respond to a product that replicates the effects of natural testosterone.
In the end, many companies advertise DIM as a cancer-fighter. It is true that diindolylmethane can reduce the growth of tumors in laboratory animals, but the animals were given the drug, not administered orally. To achieve the same result in humans, diindolylmethane has to be consumed at high doses for a long period of time. The animals that were examined had no indications of cancer for a number of years. However, they all developed liver diseases due to consuming too much diindolylmethane. A doctor can give you a better understanding of how DIM is absorbed by the body.
According to the US National Institute of Environmental Health Safety and Security, the only way to show that DIM is effective in treating breast cancer is to perform an experiment wherein cells from healthy breast cancer cells are exposed to high doses of diindolylmethane over a prolonged period of time. There are pros and negatives to using DIM just like any chemical. The ability to mimic hormones is one of the advantages. This means that you could create insulin, which can stop the proliferation of cancer cells. The cons include the fact diindolylmethane can also produce a potentially harmful chemical called DMSO. Learn more about diindolylmethane or dim here.
One of the most popular claims for diindolylmethane’s use as a treatment for various diseases is that it is an natural, antibacterial, anticancer and anti-fungal drug. These claims were rejected by the National Institute of Health after an exhaustive review of the supporting evidence. According to the Institute of Chemical Technology there were no studies that supported this claim. The Institute of Chemical Safety, through an in-depth examination of the safety profile for the firestone concluded that the data offered by pharmaceutical companies on the benefits of diindolylmethane for humans was not completely reliable.
Van der Goes and. and. published their findings in the May 2021 issue of the Journal of Toxicology and Environmental Health. pointed out numerous potential hazards associated with diindolylmethane’s use such as skin rash, allergic reactions, asthma attacks, dizziness, headaches, and respiratory problems. They also said that the recommended daily allowance for this chemical is 0.2 milligrams or one 10th of one teaspoon. It is not clear what the concentration level is when compounded with other compounds. Because this substance has not been thoroughly tested, it is not considered safe at any level.
The view abstract shows the use of diindolylmethane in cancer treatment is based on the notion that intracellular inhibition of pyruvate metabolism by flavenoids is a possibility to block and prevents accumulation of oxalates and pyruvate metabolites in renal tubule cells. However, the drug metabiplicate toxicology studies didn’t provide convincing evidence that consumption of this chemical can cause an overdose. In June 1996, the Food and Drug Administration approved this drug as a prescribed drug. According to the FDA the company that makes firestone tincture is currently in the process of completing two major trials–one in Europe and another in the United States.
The abstract of the view also reveals that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the principle of blocking intracellular inhibition of pyruvate’s pyruvate metabolite via flavenoids, thus stopping the accumulation of oxalates within renal tubule cells as well as adenine granulocyte cultures. The toxicology studies of the drug metabiplicate have not demonstrated that this chemical could cause overdose. The Food and Drug Administration approved this substance as a prescribed drug in June 1996. According to the FDA the company that makes firestone Tincture is in the process of completing two major trials in Europe and the United States. According to FDA, the FDA states that the manufacturer of firestone Tincture is conducting two major studies in Europe as well as one in the United States.